7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      MicroRNA let-7 modulates the immune response to Mycobacterium tuberculosis infection via control of A20, an inhibitor of the NF-κB pathway.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The outcome of the interaction between Mycobacterium tuberculosis (Mtb) and a macrophage depends on the interplay between host defense and bacterial immune subversion mechanisms. MicroRNAs critically regulate several host defense mechanisms, but their role in the Mtb-macrophage interplay remains unclear. MicroRNA profiling of Mtb-infected macrophages revealed the downregulation of miR-let-7f in a manner dependent on the Mtb secreted effector ESAT-6. We establish that let-7f targets A20, a feedback inhibitor of the NF-κB pathway. Expression of let-7f decreases and A20 increases with progression of Mtb infection in mice. Mtb survival is attenuated in A20-deficient macrophages, and the production of TNF, IL-1β, and nitrite, which are mediators of immunity to Mtb, is correspondingly increased. Further, let-7f overexpression diminishes Mtb survival and augments the production of cytokines including TNF and IL-1β. These results uncover a role for let-7f and its target A20 in regulating immune responses to Mtb and controlling bacterial burden.

          Related collections

          Author and article information

          Journal
          Cell Host Microbe
          Cell host & microbe
          1934-6069
          1931-3128
          Mar 11 2015
          : 17
          : 3
          Affiliations
          [1 ] Department of Chemistry, Bose Institute, Kolkata 700009, India.
          [2 ] Bioinformatics Centre, Bose Institute, Kolkata 700054, India.
          [3 ] Division of Molecular Medicine, Bose Institute, Kolkata 700054, India.
          [4 ] National Jalma Institute for Leprosy and Other Mycobacterial Diseases, Tajganj, Agra 282006, India.
          [5 ] Division of Microbiology and Molecular Medicine, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, SE-581 85 Linköping, Sweden.
          [6 ] VIB Inflammation Research Center, Ghent University, 9052 Ghent, Belgium; Department of Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium.
          [7 ] Department of Chemistry, Bose Institute, Kolkata 700009, India. Electronic address: joyoti@vsnl.com.
          Article
          S1931-3128(15)00027-X
          10.1016/j.chom.2015.01.007
          25683052
          d9ec0440-9d37-4b4f-9bb6-73987c2639b0
          Copyright © 2015 Elsevier Inc. All rights reserved.
          History

          Comments

          Comment on this article